Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children: Executive Summary
复制标题
DOI：
10.1093/cid/cir034
复制
发表时间：
2011-02-01
影响因子：
11.8
通讯作者：
Chambers, Henry F.
中科院分区：
文献类型：
--
作者：
Liu, Catherine;Bayer, Arnold;Chambers, Henry F.
美国传染病学会（IDSA）专家小组制定了耐甲氧西林金黄色葡萄球菌（MRSA）感染患者管理的循证指南。该指南旨在供护理MRSA感染的成人和儿童患者的医疗保健提供者使用。该指南讨论了与MRSA疾病相关的各种临床综合征的管理，包括皮肤和软组织感染（SSTI）、菌血症和心内膜炎、肺炎、骨和关节感染以及中枢神经系统（CNS）感染。提供了关于万古霉素给药和监测、对万古霉素敏感性降低的MRSA菌株引起的感染管理以及万古霉素治疗失败的建议。
Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.